| Identification | Back Directory | [Name]
RIBAVIRIN 5'-MONOPHOSPHATE, DILITHIUM SALT | [CAS]
66983-94-6 | [Synonyms]
1-(5-O-Phosphono-β-D-ribofuranosyl)-
RIBAVIRIN 5'-MONOPHOSPHATE, DILITHIUM SALT
Ribavirin 5'-Monophosphate DilithiuM Salt (90%) | [Molecular Formula]
C17H19Li2N4O9P | [MDL Number]
MFCD04039674 | [MOL File]
66983-94-6.mol | [Molecular Weight]
468.21 |
| Chemical Properties | Back Directory | [Appearance]
Solid | [Melting point ]
220°C dec. | [storage temp. ]
-20°C Freezer | [solubility ]
Aqueous Acid (Slightly), Water (Slightly, Sonicated) | [form ]
Solid | [color ]
Off-White to Pale Beige | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Chemical Properties]
Solid | [Uses]
A metabolite of Ribavirin. | [Uses]
Used as an antiviral agent | [Description]
Ribavirin 5''-monophosphate inhibits viral DNA and RNA replication in vitro via the strong competitive inhibition of inosine monophosphate dehydrogenase (IMPDH), with a reported Ki value of 270 nM, and thus inhibits guanosine triphosphate synthesis. This agent, a metabolite of the prodrug ribavirin , exhibits broad-spectrum antiviral activity, particularly against myxoviruses. The antiviral effects of ribavirin require conversion to the monophosphate form via adenosine kinase. The anti-HIV activity of ribavirin in cultured human lymphocytes, as well as the anti-influenza activity of this prodrug in MDCK cells, have been attributed to ribavirin 5''-monophosphate. | [storage]
Store at -20°C | [References]
[1] R C WILLIS J E S D A Carson. Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1978, 75 7: 3042-3044. DOI: 10.1073/pnas.75.7.3042
[2] D G STREETER. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1973, 70 4: 1174-1178. DOI: 10.1073/pnas.70.4.1174
[3] CLERCQ E D. Specific targets for antiviral drugs.[J]. Biochemical Journal, 1982, 205 1: 1-13. DOI: 10.1042/bj2050001
[4] J. BALZARINI. Mechanism of the potentiating effect of ribavirin on the activity of 2’,3’-dideoxyinosine against human immunodeficiency virus.[J]. The Journal of Biological Chemistry, 1991, 27 1: 21509-21514. DOI: 10.1016/s0021-9258(18)54668-8
[5] BROWNE M J. Mechanism and specificity of action of ribavirin.[J]. Antimicrobial Agents and Chemotherapy, 1979, 15 6: 747-753. DOI: 10.1128/aac.15.6.747 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList1701258/0_EN.htm |
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|